Advancing Drug Pipelines Drive Biotech Valuations as Scientific Progress Gains Financial Recognition
The biotech sector is transitioning away from a framework dominated by long-term research spending toward one in which scientific progress can be directly reflected in financial valuation. As drug ...
Automate real-time, label-free cell assays with Maestro TrayZ. Capture dynamic cellular responses with high sensitivity and ...
Cells constantly probe their environments, searching for physical cues that guide their behavior. And yet a cell's response ...
Kirill Alexandrov Artificial intelligence–designed “smart” proteins can be programmed to turn on when they detect a certain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results